NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Tesla, Inc. ("Tesla" or the "Company") (NASDAQ:TSLA) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Western District of Texas, and docketed under 25-cv-01213, is […]
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Broadwind, Inc.("Broadwind" or the "Company") (NASDAQ:BWEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Broadwind and certain of its officers and/or directors have
NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ:RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Avita and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE:INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inspire and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ:LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lantheus and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Bumble Inc. ("Bumble" or the "Company") (NASDAQ:BMBL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bumble and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ:SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sensus and certain of its officers and/or
EAST NEW YORK, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Skillz Inc. ("Skillz" or the "Company") (NYSE:SKLZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skillz and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 11, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ:AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Agios and certain of its officers and/or